Published in Br J Pharmacol on October 01, 1971
Why don't doctors use cusums? Lancet (1974) 2.04
Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis. Br Med J (1974) 1.87
Risks of everyday life--drugs. Proc R Soc Med (1976) 1.53
Assessing and allocating beds in acute medicine in east London. Br Med J (Clin Res Ed) (1983) 1.52
Interaction between debrisoquine and phenylephrine. Lancet (1970) 1.51
Patients with protracted pain: a survey conducted at The London Hospital. J Med Ethics (1977) 1.48
Logic and inference in clinical trials. Br J Clin Pharmacol (1982) 1.15
A longitudinal study of the mechanisms of action of debrisoquine and propranolol. Br J Clin Pharmacol (1978) 1.07
The effects of oral propranolol on the distensibility of resting superficial veins in man. Clin Sci (1972) 0.99
Potentiation of the cardiovascular effects of some catecholamines by a monoamine oxidase inhibitor. Br J Pharmacol (1971) 0.99
The basis of the histamine assay in skin. Br J Clin Pharmacol (1991) 0.96
The clinical assessment of analgesic drugs. Br J Clin Pharmacol (1981) 0.96
Payments to healthy volunteers--ethical problems. Br J Clin Pharmacol (1991) 0.96
Measurement in clinical trials. Br J Clin Pharmacol (1982) 0.94
Testing new drugs--the human volunteer. J Med Ethics (1978) 0.92
The chemical estimation of renal selective permeability to proteins during steroid-induced remission of the nephrotic syndrome. Clin Sci (1966) 0.89
Bopindolol: a new long acting beta-receptor antagonist; its effects on haemodynamics, and on the renin response to tilting. Br J Clin Pharmacol (1984) 0.86
A comparative account of standard and urinary urokinase. Clin Chim Acta (1967) 0.85
The basis of the histamine assay in human skin: II. Wheal formation. Br J Clin Pharmacol (1993) 0.81
Diazepam or nitrazepam? A question of cost. Br J Clin Pharmacol (1977) 0.81
Validity of cross-over trials. Br J Clin Pharmacol (1979) 0.80
The mechanism of diuresis in the nephrotic syndrome studied by a contingency technique. J Clin Pharmacol New Drugs (1971) 0.80
The significance of blood levels of drugs. Sci Basis Med Annu Rev (1972) 0.78
Research on healthy volunteers--a report of the Royal College of Physicians. Br J Clin Pharmacol (1987) 0.75
Interaction between debrisoquine and phenylephrine in man. Br J Clin Pharmacol (1974) 0.75
Clinical pharmacology: a perspective and prospect. J R Soc Med (1987) 0.75
Sequential procedures in perspective. Br J Clin Pharmacol (1974) 0.75
The hospital as a place of pain. J Med Ethics (1980) 0.75
Models of agonist-antagonist interaction [proceedings]. Br J Pharmacol (1976) 0.75
Problems in controlled trials--a critical response. J Med Ethics (1983) 0.75
Interaction between debrisoquine and phenylephrine in man. Br J Pharmacol (1973) 0.75
A controlled trial of practolol in mild hypertension. Br J Clin Pharmacol (1974) 0.75
Suspected interaction between phenindione and ethyloestrenol. Lancet (1968) 0.75
Antipyrine and propranolol disposition in malnutrition. East Afr Med J (1978) 0.75
Teaching and learning about terminal care. Med Educ (1986) 0.75
Trade names or approved names. Part IV. The solution. How should we prescribe? Postgrad Med J (1974) 0.75
Determination of plasma nefopam by liquid chromatography and electrochemical detection. J Chromatogr (1990) 0.75
The design of pharmacological experiments using unbiased models of agonist-antagonist interaction. J Pharmacol Exp Ther (1978) 0.75
Drug trials: Allowing for cost. Lancet (1977) 0.75
Penicillamine in rheumatoid arthritis. Lancet (1973) 0.75
Right to die. Lancet (1970) 0.75
The information content of pharmacological experiments [proceedings]. Br J Pharmacol (1980) 0.75
Letter: Cusums. Lancet (1974) 0.75
An adjustable column end-piece for gel filtration. J Chromatogr (1966) 0.75
When to withdraw or withhold treatment. Adverse Drug React Toxicol Rev (1999) 0.75
The mechanism of a drug effect in man studied by a multivariant technic. Br J Pharmacol (1970) 0.75
Penicillamine in rheumatoid arthritis. Lancet (1973) 0.75
Letter: Double-blind trials. Lancet (1976) 0.75
Teratogenic effects of some calcium channel blocking agents in Xenopus embryos. Pharmacol Toxicol (1989) 0.75